---
title: "LIVZON PHARMA adjusts the maximum cost of acquiring its Vietnamese peer to RMB 1.85 billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/271115541.md"
description: "LIVZON PHARMA announced that it has entered into a supplementary agreement with the sellers SK Investment, Sunrise, and KBA regarding the acquisition of a total of 64.81% equity in the Vietnamese listed company Imexpharm Corporation, which extends the completion date to June 30, 2026. The adjusted maximum cash consideration for this transaction is 6.891 trillion Vietnamese Dong (approximately 1.846 billion RMB)"
datetime: "2025-12-30T14:13:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271115541.md)
  - [en](https://longbridge.com/en/news/271115541.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271115541.md)
---

# LIVZON PHARMA adjusts the maximum cost of acquiring its Vietnamese peer to RMB 1.85 billion

LIVZON PHARMA (01513.HK) announced that it has entered into a supplemental agreement with the sellers SK Investment, Sunrise, and KBA regarding the acquisition of a total of 64.81% equity in the Vietnamese listed company Imexpharm Corporation, extending the completion date to June 30, 2026. The adjusted maximum cash consideration for this transaction is 6.891 trillion Vietnamese Dong (approximately 1.846 billion RMB)

### Related Stocks

- [000513.CN](https://longbridge.com/en/quote/000513.CN.md)
- [01513.HK](https://longbridge.com/en/quote/01513.HK.md)

## Related News & Research

- [Livzon Pharmaceutical’s First-Quarter Profit Slips as Policy Shift and Seasonality Hit Revenue](https://longbridge.com/en/news/283852429.md)
- [CICC Reaffirms Their Buy Rating on Livzon Pharmaceutical Group (LVZPF)](https://longbridge.com/en/news/282769048.md)
- [Việt Nam eyes balanced, sustainable trade ties with US](https://longbridge.com/en/news/286951723.md)
- [China retail giant Meiyijia has task cut out in Vietnam’s competitive retail market](https://longbridge.com/en/news/286978968.md)
- [ACWA Power posts analyst day presentation on business model, consolidation and IFRS 18 impacts](https://longbridge.com/en/news/287073835.md)